Form 4: LENSAR COO Alan Connaughton Receives RSU Grant
Statement of Changes in Beneficial Ownership
LENSAR, Inc. Chief Operating Officer Alan B. Connaughton was granted 34,843 restricted stock units as part of an equity incentive plan.
Summary
- Alan B. Connaughton, Chief Operating Officer of LENSAR, Inc., acquired 34,843 restricted stock units (RSUs) on June 3, 2026.
- The RSUs represent a contingent right to receive one share of common stock per unit.
- The grant increases the reporting person's total beneficial ownership to 389,173 shares of common stock.
- The RSUs are subject to a four-year vesting schedule in equal annual installments, contingent upon continued service.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of executive interests with long-term shareholder value through equity-based compensation.
- Retention of key leadership personnel via multi-year vesting requirements.
Negatives
- Potential for future shareholder dilution upon the eventual settlement of the RSUs into common stock.
Risks
- Vesting is subject to the reporting person's continued service to the issuer, creating a dependency on key personnel retention.
Future Outlook
The RSUs will vest in four substantially equal annual installments, ensuring the executive remains incentivized over the next four years.
Industry Context
StockSavvy.ai notes that equity grants to C-suite executives are standard practice in the medical device sector to ensure leadership alignment with long-term corporate performance and retention.
Comparison to Industry Standards
- The use of four-year vesting schedules for RSU grants is consistent with standard corporate governance practices for publicly traded medical technology companies.
- The grant size is commensurate with typical executive compensation packages for a COO role in a company of LENSAR's market capitalization.
Stakeholder Impact
- Shareholders may experience minor dilution upon the future conversion of these RSUs into common stock.
Next Steps
- Vesting of the first installment of RSUs on the first anniversary of the grant date, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 06/03/2026 | Date of the RSU grant transaction. |
| 06/05/2026 | Date the Form 4 was filed with the SEC. |
Keywords
LENSAR, LNSR, Form 4, Insider Transaction, Restricted Stock Units, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.